2017
DOI: 10.1002/bjs.10692
|View full text |Cite
|
Sign up to set email alerts
|

Improving outcomes in patients with resectable pancreatic cancer

Abstract: State of the art

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
9
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 19 publications
0
9
0
Order By: Relevance
“…Optimizing pathways, reducing variation in practice, and national guidance can all help achieve improvement. While more substantial improvements may occur from novel chemotherapeutics, it is clear that outcomes and patient experience can be improved by focusing on optimizing every part of the patient pathway, from diagnosis to treatment [36]. It is therefore essential that current practice and its variation and effect on patient outcomes are evaluated.…”
Section: Discussionmentioning
confidence: 99%
“…Optimizing pathways, reducing variation in practice, and national guidance can all help achieve improvement. While more substantial improvements may occur from novel chemotherapeutics, it is clear that outcomes and patient experience can be improved by focusing on optimizing every part of the patient pathway, from diagnosis to treatment [36]. It is therefore essential that current practice and its variation and effect on patient outcomes are evaluated.…”
Section: Discussionmentioning
confidence: 99%
“…Despite advances in diagnostic methods, operative techniques and perioperative management over the past few decades, patients with pancreatic cancer have a poor prognosis, with a 5‐year survival rate of 8 per cent. Although surgical resection is the only treatment that offers long‐term survival in selected patients with resectable pancreatic cancer, up to 80 per cent of patients develop locoregional and/or distant recurrence after primary pancreatectomy with curative intent, and this may contribute to the poor prognosis.…”
Section: Introductionmentioning
confidence: 99%
“…Despite the challenges presented by pancreatic cancer, after decades of lack of improvement in very poor outcomes, there is now reason for cautious optimism 1 . Systematic improvements across pathways such as improved outcomes with surgery, strategies to treat borderline or locally advanced pancreatic cancer, multimodal chemotherapy and a focus upon improving the patient experience are some of the causes for this optimism 2 .…”
Section: Introductionmentioning
confidence: 99%